These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6385178)

  • 1. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
    Arteaga A; Velasco N; Szegedi AM; Pellegrino MR; López G; Foradori A; Acosta AM
    Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 3. C-peptide response to glycaemic stimuli.
    Samal KC; Das S; Parija CR; Tripathy BB
    J Assoc Physicians India; 1987 May; 35(5):362-4. PubMed ID: 3320022
    [No Abstract]   [Full Text] [Related]  

  • 4. C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.
    Taskinen MR; Groop L
    Ann Clin Res; 1984; 16(2):118-27. PubMed ID: 6380385
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion.
    Yabe D; Kuroe A; Ohya M; Watanabe K; Kitatani N; Oku M; Kurose T; Seino Y
    Diabetes Res Clin Pract; 2008 Nov; 82(2):e1-4. PubMed ID: 18789550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 7. Appearance of type II diabetes mellitus in type I diabetic recipients of pancreas allografts.
    Hunsicker LG; Smith JL; Yuh WT; Wright FH; Goddard L; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2852-3. PubMed ID: 2468245
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the radioimmunological determination of blood insulin by means of 125-I-insulin of high specific activity.
    Lawecki J; Rogala H; Kowalski H
    Pol Med J; 1970; 9(6):1338-45. PubMed ID: 5534059
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic reserve and insulin dose in type 2 diabetic patients.
    Calle JR; Rubio MA; Calle-Pascual AL; Bordiu E; Marañés JP
    Diabetes Res; 1993; 23(3):123-9. PubMed ID: 7712686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The importance of strict control of blood glucose at the onset and during the remission stage in newly diagnosed diabetic children].
    Vavrinec J; Lébl J; Zizkovský V; Dvorák P; Snajderová M
    Cesk Pediatr; 1988 May; 43(5):325-8. PubMed ID: 3042170
    [No Abstract]   [Full Text] [Related]  

  • 11. C-peptide pattern in patients with pancreatic cancer.
    Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
    Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of pancreatic insulin reserve on the metabolic control of type I and II diabetes mellitus].
    Calle Fernández JR; Rubio Herrera MA; Calle Pascual AL; Bordíu Obanza E; Marañes Pallardo JP
    An Med Interna; 1994 Jul; 11(7):322-7. PubMed ID: 7981358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma insulin in normal children and in diabetic children treated with intramuscular injections of insulin (author's transl)].
    Gouedard H; Vicq D
    Ann Pediatr (Paris); 1981 Sep; 28(7):475-80. PubMed ID: 7025727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies between median blood sugar, hemoglobin A, triglycerides and C-peptide in normal-weight insulin and non-insulin dependent diabetics].
    Stradner F; Ulreich A; Zeichen R; Pfeiffer KP
    Wien Med Wochenschr; 1983 Sep; 133(18):459-61. PubMed ID: 6649657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The artificial endocrine pancreas in clinical medicine and in research].
    Pfeiffer EF; Beischer W; Thum C; Clemens AH
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():279-96. PubMed ID: 796524
    [No Abstract]   [Full Text] [Related]  

  • 16. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
    Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
    Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma insulin, C-peptide and glucose concentrations in type I diabetic children after a morning injection of insulin (author's transl)].
    Desjeux JF; Vicq D; Gouedard H; Dieterlen P; Gernez-Lestradet C; Lestradet H
    Arch Fr Pediatr; 1981; 38(6):411-5. PubMed ID: 7027987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
    Beischer W
    Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha and development of type 1 diabetes: a case without insulin resistance.
    Tohda G; Oida K; Higashi S; Hayashi T; Miyamori I
    Diabetes Care; 1998 Oct; 21(10):1774. PubMed ID: 9773746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.